Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 21NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1461Pancreatic Neoplasms 832Stomach Neoplasms 692Carcinoma, Hepatocellular 647Carcinoma, Non-Small-Cell Lung 540Neoplasms 459Breast Neoplasms 369Ovarian Neoplasms 338Neoplasm Metastasis 336Colonic Neoplasms 331Esophageal Neoplasms 297Liver Neoplasms 265Melanoma 255Lung Neoplasms 245Squamous Cell Carcinoma of Head and Neck 210Cholangiocarcinoma 180Carcinoma, Renal Cell 180Prostatic Neoplasms 175Head and Neck Neoplasms 172Triple Negative Breast Neoplasms 162Endometrial Neoplasms 160Rectal Neoplasms 159Uterine Cervical Neoplasms 155Gastrointestinal Neoplasms 142Urinary Bladder Neoplasms 139Biliary Tract Neoplasms 135Gastrointestinal Stromal Tumors 108Sarcoma 104Esophageal Squamous Cell Carcinoma 102Small Cell Lung Carcinoma 95

Interventions

Deamino Arginine Vasopressin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Gastrointestinal Hemorrhage × Gastrointestinal × Clear all
NCT01623206 2017-08-24

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Laboratorio Elea Phoenix S.A.

Phase 2 Completed
30 enrolled
Gastrointestinal

Gastrointestinal Hemorrhage, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡